These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 31249382)
21. Neuropathology of mood disorders: do we see the stigmata of inflammation? Mechawar N; Savitz J Transl Psychiatry; 2016 Nov; 6(11):e946. PubMed ID: 27824355 [TBL] [Abstract][Full Text] [Related]
22. Glial Markers of Suicidal Behavior in the Human Brain-A Systematic Review of Postmortem Studies. Yamamoto M; Sakai M; Yu Z; Nakanishi M; Yoshii H Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891940 [TBL] [Abstract][Full Text] [Related]
23. Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence. Zhang X; Alnafisah RS; Hamoud AA; Shukla R; McCullumsmith RE; O'Donovan SM Adv Neurobiol; 2021; 26():153-172. PubMed ID: 34888835 [TBL] [Abstract][Full Text] [Related]
24. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated. Sneeboer MAM; Snijders GJLJ; Berdowski WM; Fernández-Andreu A; ; van Mierlo HC; Berdenis van Berlekom A; Litjens M; Kahn RS; Hol EM; de Witte LD Transl Psychiatry; 2019 May; 9(1):153. PubMed ID: 31127084 [TBL] [Abstract][Full Text] [Related]
25. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study. Haarman BC; Burger H; Doorduin J; Renken RJ; Sibeijn-Kuiper AJ; Marsman JB; de Vries EF; de Groot JC; Drexhage HA; Mendes R; Nolen WA; Riemersma-Van der Lek RF Brain Behav Immun; 2016 Aug; 56():21-33. PubMed ID: 26348581 [TBL] [Abstract][Full Text] [Related]
26. A comparison study of metabolic profiles, immunity, and brain gray matter volumes between patients with bipolar disorder and depressive disorder. Bai YM; Chen MH; Hsu JW; Huang KL; Tu PC; Chang WC; Su TP; Li CT; Lin WC; Tsai SJ J Neuroinflammation; 2020 Jan; 17(1):42. PubMed ID: 32000805 [TBL] [Abstract][Full Text] [Related]
27. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review. van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047 [TBL] [Abstract][Full Text] [Related]
28. Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. Watkins CC; Sawa A; Pomper MG Transl Psychiatry; 2014 Jan; 4(1):e350. PubMed ID: 24448212 [TBL] [Abstract][Full Text] [Related]
29. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder. Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074 [TBL] [Abstract][Full Text] [Related]
30. Inflammatory Biomarkers, Cognitive Functioning, and Brain Imaging Abnormalities in Bipolar Disorder: A Systematic Review. Mario A; Ivana L; Anita M; Silvio M; Claudia A; Mariaclaudia M; Antonello B Clin Neuropsychiatry; 2024 Feb; 21(1):32-62. PubMed ID: 38559427 [TBL] [Abstract][Full Text] [Related]
31. Immune-based strategies for mood disorders: facts and challenges. Colpo GD; Leboyer M; Dantzer R; Trivedi MH; Teixeira AL Expert Rev Neurother; 2018 Feb; 18(2):139-152. PubMed ID: 29179585 [TBL] [Abstract][Full Text] [Related]
32. The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application. Niu Z; Yang L; Wu X; Zhu Y; Chen J; Fang Y Neurosci Bull; 2019 Aug; 35(4):595-607. PubMed ID: 31214924 [TBL] [Abstract][Full Text] [Related]
33. Cytokines in bipolar disorder: paving the way for neuroprogression. Barbosa IG; Bauer ME; Machado-Vieira R; Teixeira AL Neural Plast; 2014; 2014():360481. PubMed ID: 25313338 [TBL] [Abstract][Full Text] [Related]
34. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Anderson G; Maes M Curr Psychiatry Rep; 2015 Feb; 17(2):8. PubMed ID: 25620790 [TBL] [Abstract][Full Text] [Related]
35. Role of neuro-immunological factors in the pathophysiology of mood disorders. Bhattacharya A; Derecki NC; Lovenberg TW; Drevets WC Psychopharmacology (Berl); 2016 May; 233(9):1623-36. PubMed ID: 26803500 [TBL] [Abstract][Full Text] [Related]
36. Cognitive deficits in bipolar disorders: Implications for emotion. Lima IMM; Peckham AD; Johnson SL Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773 [TBL] [Abstract][Full Text] [Related]
37. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment. Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686 [TBL] [Abstract][Full Text] [Related]
38. Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. Rowland T; Perry BI; Upthegrove R; Barnes N; Chatterjee J; Gallacher D; Marwaha S Br J Psychiatry; 2018 Sep; 213(3):514-525. PubMed ID: 30113291 [TBL] [Abstract][Full Text] [Related]
39. Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder. Bond DJ; Andreazza AC; Hughes J; Dhanoa T; Torres IJ; Kozicky JM; Young LT; Lam RW; Yatham LN Psychoneuroendocrinology; 2016 Mar; 65():76-83. PubMed ID: 26731572 [TBL] [Abstract][Full Text] [Related]
40. Lactate in bipolar disorder: A systematic review and meta-analysis. Kuang H; Duong A; Jeong H; Zachos K; Andreazza AC Psychiatry Clin Neurosci; 2018 Aug; 72(8):546-555. PubMed ID: 29726068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]